Skip to main content
Top
Published in: Journal of Nuclear Cardiology 5/2017

01-10-2017 | CME ARTICLE Review Article

Cardiac autonomic innervation

Authors: Hina K. Jamali, MD, Fahad Waqar, MD, Myron C. Gerson, MD

Published in: Journal of Nuclear Cardiology | Issue 5/2017

Login to get access

Abstract

The autonomic nervous system plays a key role in regulating changes in the cardiovascular system and its adaptation to various human body functions. The sympathetic arm of the autonomic nervous system is associated with the fight and flight response, while the parasympathetic division is responsible for the restorative effects on heart rate, blood pressure, and contractility. Disorders involving these two divisions can lead to, and are seen as, a manifestation of most common cardiovascular disorders. Over the last few decades, extensive research has been performed establishing imaging techniques to quantify the autonomic dysfunction associated with various cardiovascular disorders. Additionally, several techniques have been tested with variable success in modulating the cardiac autonomic nervous system as treatment for these disorders. In this review, we summarize basic anatomy, physiology, and pathophysiology of the cardiac autonomic nervous system including adrenergic receptors. We have also discussed several imaging modalities available to aid in diagnosis of cardiac autonomic dysfunction and autonomic modulation techniques, including pharmacologic and device-based therapies, that have been or are being tested currently.
Appendix
Available only for authorised users
Literature
1.
go back to reference Palma JA, Benarroch EE. Neural control of the heart: recent concepts and clinical correlations. Neurology. 2014;83(3):261–71.PubMedCrossRef Palma JA, Benarroch EE. Neural control of the heart: recent concepts and clinical correlations. Neurology. 2014;83(3):261–71.PubMedCrossRef
2.
go back to reference Ciriello J, Calaresu FR. Medullary origin of vagal preganglionic axons to the heart of the cat. J Auton Nerv Syst. 1982;5(1):9–22.PubMedCrossRef Ciriello J, Calaresu FR. Medullary origin of vagal preganglionic axons to the heart of the cat. J Auton Nerv Syst. 1982;5(1):9–22.PubMedCrossRef
3.
go back to reference Dae MW, O’Connell JW, Botvinick EH, Ahearn T, Yee E, Huberty JP, et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation. 1989;79:634–44.PubMedCrossRef Dae MW, O’Connell JW, Botvinick EH, Ahearn T, Yee E, Huberty JP, et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation. 1989;79:634–44.PubMedCrossRef
4.
go back to reference Cravo SL, Morrison SF. The caudal ventrolateral medulla is a source of tonic sympathoinhibition. Brain Res. 1993;621(1):133–6.PubMedCrossRef Cravo SL, Morrison SF. The caudal ventrolateral medulla is a source of tonic sympathoinhibition. Brain Res. 1993;621(1):133–6.PubMedCrossRef
5.
go back to reference Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247(2):289–98.PubMedCrossRef Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247(2):289–98.PubMedCrossRef
6.
go back to reference Janes RD, Brandys JC, Hopkins DA, Johnstone DE, Murphy DA, Armour JA. Anatomy of human extrinsic cardiac nerves and ganglia. Am J Cardiol. 1986;57(4):299–309.PubMedCrossRef Janes RD, Brandys JC, Hopkins DA, Johnstone DE, Murphy DA, Armour JA. Anatomy of human extrinsic cardiac nerves and ganglia. Am J Cardiol. 1986;57(4):299–309.PubMedCrossRef
7.
go back to reference Woodman OL, Vatner SF. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog. J Pharmacol Exp Ther. 1986;237(1):86–91.PubMed Woodman OL, Vatner SF. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog. J Pharmacol Exp Ther. 1986;237(1):86–91.PubMed
8.
go back to reference Hirono O, Kubota I, Minamihaba O, Fatema K, Kato S, Nakamura H, et al. Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral beta2-adrenoceptor agonists. Am Heart J. 2001;142(6):E11.PubMedCrossRef Hirono O, Kubota I, Minamihaba O, Fatema K, Kato S, Nakamura H, et al. Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral beta2-adrenoceptor agonists. Am Heart J. 2001;142(6):E11.PubMedCrossRef
9.
go back to reference Lowe MD, Rowland E, Brown MJ, Grace AA. Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium. Heart. 2001;86(1):45–51.PubMedPubMedCentralCrossRef Lowe MD, Rowland E, Brown MJ, Grace AA. Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium. Heart. 2001;86(1):45–51.PubMedPubMedCentralCrossRef
10.
go back to reference Young MA, Vatner DE, Vatner SF. Alpha- and beta-adrenergic control of large coronary arteries in conscious calves. Basic Res Cardiol. 1990;85(Suppl 1):97–109.PubMed Young MA, Vatner DE, Vatner SF. Alpha- and beta-adrenergic control of large coronary arteries in conscious calves. Basic Res Cardiol. 1990;85(Suppl 1):97–109.PubMed
11.
go back to reference Chilian WM. Functional distribution of alpha 1- and alpha 2-adrenergic receptors in the coronary microcirculation. Circulation. 1991;84(5):2108–22.PubMedCrossRef Chilian WM. Functional distribution of alpha 1- and alpha 2-adrenergic receptors in the coronary microcirculation. Circulation. 1991;84(5):2108–22.PubMedCrossRef
12.
go back to reference Wang GY, McCloskey DT, Turcato S, Swigart PM, Simpson PC, Baker AJ. Contrasting inotropic responses to alpha1-adrenergic receptor stimulation in left versus right ventricular myocardium. Am J Physiol Heart Circ Physiol. 2006;291(4):H2013–7.PubMedCrossRef Wang GY, McCloskey DT, Turcato S, Swigart PM, Simpson PC, Baker AJ. Contrasting inotropic responses to alpha1-adrenergic receptor stimulation in left versus right ventricular myocardium. Am J Physiol Heart Circ Physiol. 2006;291(4):H2013–7.PubMedCrossRef
13.
go back to reference Vatner SF, Higgins CB, Braunwald E. Effects of norepinephrine on coronary circulation and left ventricular dynamics in the conscious dog. Circ Res. 1974;34:812–23.PubMedCrossRef Vatner SF, Higgins CB, Braunwald E. Effects of norepinephrine on coronary circulation and left ventricular dynamics in the conscious dog. Circ Res. 1974;34:812–23.PubMedCrossRef
14.
go back to reference Orlick AE, Ricci DR, Alderman EL, Stinson EB, Harrison DC. Effects of alpha adrenergic blockade upon coronary hemodynamics. J Clin Invest. 1978;62:459–67.PubMedPubMedCentralCrossRef Orlick AE, Ricci DR, Alderman EL, Stinson EB, Harrison DC. Effects of alpha adrenergic blockade upon coronary hemodynamics. J Clin Invest. 1978;62:459–67.PubMedPubMedCentralCrossRef
15.
go back to reference Bristow MR, Hershberger RE, Port JD, Minobe W, Rasmussen R. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol. 1989;35(3):295–303.PubMed Bristow MR, Hershberger RE, Port JD, Minobe W, Rasmussen R. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol. 1989;35(3):295–303.PubMed
16.
go back to reference Ng GA, Brack KE, Patel VH, Coote JH. Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. Cardiovasc Res. 2007;73(4):750–60.PubMedCrossRef Ng GA, Brack KE, Patel VH, Coote JH. Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. Cardiovasc Res. 2007;73(4):750–60.PubMedCrossRef
17.
go back to reference Ng GA, Mantravadi R, Walker WH, Ortin WG, Choi BR, de Groat W, et al. Sympathetic nerve stimulation produces spatial heterogeneities of action potential restitution. Heart rhythm. 2009;6:696–706.PubMedCrossRef Ng GA, Mantravadi R, Walker WH, Ortin WG, Choi BR, de Groat W, et al. Sympathetic nerve stimulation produces spatial heterogeneities of action potential restitution. Heart rhythm. 2009;6:696–706.PubMedCrossRef
18.
19.
go back to reference Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, et al. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest. 1998;102(7):1377–84.PubMedPubMedCentralCrossRef Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, et al. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest. 1998;102(7):1377–84.PubMedPubMedCentralCrossRef
20.
go back to reference Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N, Abraham WT, et al. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res. 2000;86(8):834–40.PubMedCrossRef Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N, Abraham WT, et al. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res. 2000;86(8):834–40.PubMedCrossRef
21.
go back to reference Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 2002;347(15):1135–42.PubMedCrossRef Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 2002;347(15):1135–42.PubMedCrossRef
22.
go back to reference Ma ST, Zhao W, Liu B, Jia RY, Zhao CJ, Cui LQ. Association between β1 adrenergic receptor gene Arg389Gly polymorphism and risk of heart failure: a meta-analysis. Genet Mol Res. 2015;14(2):5922–9.PubMedCrossRef Ma ST, Zhao W, Liu B, Jia RY, Zhao CJ, Cui LQ. Association between β1 adrenergic receptor gene Arg389Gly polymorphism and risk of heart failure: a meta-analysis. Genet Mol Res. 2015;14(2):5922–9.PubMedCrossRef
23.
go back to reference Reddy S, Fung A, Manlhiot C, Tierney ES, Chung WK, Blume E, et al. Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy. Pediatr Res. 2015;77(2):363–9.PubMedCrossRef Reddy S, Fung A, Manlhiot C, Tierney ES, Chung WK, Blume E, et al. Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy. Pediatr Res. 2015;77(2):363–9.PubMedCrossRef
24.
go back to reference Hainsworth R. Cardiovascular control from cardiac and pulmonary vascular receptors. Exp Physiol. 2014;99(2):312–9.PubMedCrossRef Hainsworth R. Cardiovascular control from cardiac and pulmonary vascular receptors. Exp Physiol. 2014;99(2):312–9.PubMedCrossRef
25.
go back to reference Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res. 2014;114:1004–21.PubMedCrossRef Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res. 2014;114:1004–21.PubMedCrossRef
27.
go back to reference Eckberg DL. Point:counterpoint: respiratory sinus arrhythmia is due to a central mechanism vs. respiratory sinus arrhythmia is due to the baroreflex mechanism. J Appl Physiol. 2009;106(5):1740–2.PubMedCrossRef Eckberg DL. Point:counterpoint: respiratory sinus arrhythmia is due to a central mechanism vs. respiratory sinus arrhythmia is due to the baroreflex mechanism. J Appl Physiol. 2009;106(5):1740–2.PubMedCrossRef
28.
go back to reference Dampney RA, Horiuchi J. Functional organisation of central cardiovascular pathways: studies using c-fos gene expression. Prog Neurobiol. 2003;71(5):359–84.PubMedCrossRef Dampney RA, Horiuchi J. Functional organisation of central cardiovascular pathways: studies using c-fos gene expression. Prog Neurobiol. 2003;71(5):359–84.PubMedCrossRef
29.
go back to reference Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol. 1983;1(1):90–102.PubMedCrossRef Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol. 1983;1(1):90–102.PubMedCrossRef
30.
go back to reference Meller ST, Gebhart GF. A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain. Neuroscience. 1992;48(3):501–24.PubMedCrossRef Meller ST, Gebhart GF. A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain. Neuroscience. 1992;48(3):501–24.PubMedCrossRef
31.
go back to reference Malliani A, Schwartz PJ, Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol. 1969;217(3):703–9.PubMed Malliani A, Schwartz PJ, Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol. 1969;217(3):703–9.PubMed
32.
go back to reference Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol. 2008;51(18):1725–33.PubMedCrossRef Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol. 2008;51(18):1725–33.PubMedCrossRef
33.
go back to reference Travin MI. Clinical applications of myocardial innervation imaging. Cardiol Clin. 2016;34:133–47.PubMedCrossRef Travin MI. Clinical applications of myocardial innervation imaging. Cardiol Clin. 2016;34:133–47.PubMedCrossRef
34.
go back to reference Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. ADMIRE-HF investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212–21.PubMedCrossRef Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. ADMIRE-HF investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212–21.PubMedCrossRef
35.
go back to reference Dae MW, O’Connell JW, Botvinick E, Chin MC. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res. 1995;30:270–80.PubMedCrossRef Dae MW, O’Connell JW, Botvinick E, Chin MC. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res. 1995;30:270–80.PubMedCrossRef
36.
go back to reference Matsunari I, Aoki H, Nomura Y, Takeda N, Chen WP, Taki J, et al. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging. 2010;3(5):595–603.PubMedCrossRef Matsunari I, Aoki H, Nomura Y, Takeda N, Chen WP, Taki J, et al. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging. 2010;3(5):595–603.PubMedCrossRef
37.
go back to reference Schwaiger M, Kalff V, Rosenspire K, Haka MS, Molina E, Hutchins GD, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation. 1990;82(2):457–64.PubMedCrossRef Schwaiger M, Kalff V, Rosenspire K, Haka MS, Molina E, Hutchins GD, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation. 1990;82(2):457–64.PubMedCrossRef
38.
go back to reference Riemann B, Schäfers M, Law MP, Wichter T, Schober O. Radioligands for imaging myocardial alpha- and beta-adrenoceptors. Nuklearmedizin. 2003;42(1):4–9.PubMed Riemann B, Schäfers M, Law MP, Wichter T, Schober O. Radioligands for imaging myocardial alpha- and beta-adrenoceptors. Nuklearmedizin. 2003;42(1):4–9.PubMed
39.
go back to reference Naya M, Tsukamoto T, Morita K, Katoh C, Nishijima K, Komatsu H, et al. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy. J Nucl Med. 2009;50(2):220–5.PubMedCrossRef Naya M, Tsukamoto T, Morita K, Katoh C, Nishijima K, Komatsu H, et al. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy. J Nucl Med. 2009;50(2):220–5.PubMedCrossRef
40.
go back to reference de Jong RM, Willemsen AT, Slart RH, Blanksma PK, van Waarde A, Cornel JH, et al. Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388. Eur J Nucl Med Mol Imaging. 2005;32(4):443–7.PubMedCrossRef de Jong RM, Willemsen AT, Slart RH, Blanksma PK, van Waarde A, Cornel JH, et al. Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388. Eur J Nucl Med Mol Imaging. 2005;32(4):443–7.PubMedCrossRef
41.
go back to reference Yu M, Bozek J, Lamoy M, Guaraldi M, Silva P, Kagan M, et al. Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models. Circ Cardiovasc Imaging. 2011;4(4):435–43.PubMedCrossRef Yu M, Bozek J, Lamoy M, Guaraldi M, Silva P, Kagan M, et al. Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models. Circ Cardiovasc Imaging. 2011;4(4):435–43.PubMedCrossRef
42.
go back to reference Haga K, Kruse AC, Asada H, Yurugi-Kobayashi T, Shiroishi M, Zhang C. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature. 2012;482:547–51.PubMedPubMedCentralCrossRef Haga K, Kruse AC, Asada H, Yurugi-Kobayashi T, Shiroishi M, Zhang C. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature. 2012;482:547–51.PubMedPubMedCentralCrossRef
43.
go back to reference LeGuludec D, Delforge J, Dolle F. Imaging parasympathetic cardiac innervation with PET. In: Slart RHJA, Tio RA, Elsinga PH, Schwaiger M, editors. Autonomic innervation of the heart. Berlin: Springer-Verlag; 2015. p. 111–35. LeGuludec D, Delforge J, Dolle F. Imaging parasympathetic cardiac innervation with PET. In: Slart RHJA, Tio RA, Elsinga PH, Schwaiger M, editors. Autonomic innervation of the heart. Berlin: Springer-Verlag; 2015. p. 111–35.
44.
go back to reference Gjerløff T, Jakobsen S, Nahimi A, Munk OL, Bender D, Alstrup AKO, et al. In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses. J Nucl Med. 2014;55(11):1818–24.PubMedCrossRef Gjerløff T, Jakobsen S, Nahimi A, Munk OL, Bender D, Alstrup AKO, et al. In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses. J Nucl Med. 2014;55(11):1818–24.PubMedCrossRef
45.
go back to reference Thomas J, Marks B. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978;41:233–43.PubMedCrossRef Thomas J, Marks B. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978;41:233–43.PubMedCrossRef
46.
go back to reference Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–23.PubMedCrossRef Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–23.PubMedCrossRef
47.
go back to reference Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8:491–8.PubMedCrossRef Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8:491–8.PubMedCrossRef
48.
go back to reference Patel HC, Rosen SD, Lindsay A, Hayward C, Lyon AR, di Mario C. Targeting the autonomic nervous system: measuring autonomic function and novel devices for heart failure management. Int J Cardiol. 2013;170(2):107–17.PubMedCrossRef Patel HC, Rosen SD, Lindsay A, Hayward C, Lyon AR, di Mario C. Targeting the autonomic nervous system: measuring autonomic function and novel devices for heart failure management. Int J Cardiol. 2013;170(2):107–17.PubMedCrossRef
49.
go back to reference Cygankiewicz I, Zareba W, Vazquez R, Vallverdu M, Gonzalez-Juanatey JR, Valdes M, et al. Muerte subita en insuficiencia cardiaca investigators. Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. Heart Rhythm. 2008;5(8):1095–102.PubMedCrossRef Cygankiewicz I, Zareba W, Vazquez R, Vallverdu M, Gonzalez-Juanatey JR, Valdes M, et al. Muerte subita en insuficiencia cardiaca investigators. Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. Heart Rhythm. 2008;5(8):1095–102.PubMedCrossRef
50.
go back to reference La Rovere M, Pinna G, Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol. 2008;13:191–207.PubMedCrossRef La Rovere M, Pinna G, Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol. 2008;13:191–207.PubMedCrossRef
51.
go back to reference La Rovere MT, Pinna GD, Maestri R, Robbi E, Caporotondi A, Guazzotti G, et al. Prognostic implication of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol. 2009;53:193–9.PubMedCrossRef La Rovere MT, Pinna GD, Maestri R, Robbi E, Caporotondi A, Guazzotti G, et al. Prognostic implication of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol. 2009;53:193–9.PubMedCrossRef
52.
go back to reference Carrió I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010;3(1):92–100.PubMedCrossRef Carrió I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010;3(1):92–100.PubMedCrossRef
53.
go back to reference Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ. Altered expression of beta-adrenergic receptor kinase and beta-1-adrenergic receptors in the failing human heart. Circulation. 1993;87(2):454–63.PubMedCrossRef Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ. Altered expression of beta-adrenergic receptor kinase and beta-1-adrenergic receptors in the failing human heart. Circulation. 1993;87(2):454–63.PubMedCrossRef
54.
go back to reference Caldwell JH, Link JM, Levy WC, Poole JE, Stratton JR. Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med. 2008;49(2):234–41.PubMedCrossRef Caldwell JH, Link JM, Levy WC, Poole JE, Stratton JR. Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med. 2008;49(2):234–41.PubMedCrossRef
55.
go back to reference Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boiseel JP. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation. 1998;98:1184–91.PubMedCrossRef Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boiseel JP. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation. 1998;98:1184–91.PubMedCrossRef
56.
go back to reference Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation. 1997;96(4):1173–9.PubMedCrossRef Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation. 1997;96(4):1173–9.PubMedCrossRef
57.
go back to reference Aggarwal A, Esler MD, Morris MJ, Lambert G, Kaye DM. Regional sympathetic effects of low-dose clonidine in heart failure. Hypertension. 2003;41(3):553–7.PubMedCrossRef Aggarwal A, Esler MD, Morris MJ, Lambert G, Kaye DM. Regional sympathetic effects of low-dose clonidine in heart failure. Hypertension. 2003;41(3):553–7.PubMedCrossRef
58.
go back to reference Moorman AJ, Stratton JR, Levy WC. Clonidine therapy in patients with heart failure improves exercise efficiency, functional class and symptoms. Int J Cardiol. 2011;150(3):372–3.PubMedCrossRef Moorman AJ, Stratton JR, Levy WC. Clonidine therapy in patients with heart failure improves exercise efficiency, functional class and symptoms. Int J Cardiol. 2011;150(3):372–3.PubMedCrossRef
59.
go back to reference Cohn JN, Pfeffer MA, Rouleau J, Sharpe N, Swedberg K, Straub M, et al. MOXCON investigators. adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail. 2003;5:659–67.PubMedCrossRef Cohn JN, Pfeffer MA, Rouleau J, Sharpe N, Swedberg K, Straub M, et al. MOXCON investigators. adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail. 2003;5:659–67.PubMedCrossRef
60.
go back to reference Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, et al. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol. 2013;162(3):189–92.PubMedCrossRef Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, et al. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol. 2013;162(3):189–92.PubMedCrossRef
61.
go back to reference Taborsky M, Lazarova ML, Vaclavik J. The effect of renal denervation in patients with advanced heart failure. Eur Heart J. 2012;33:517 [Abstract Supplement]. Taborsky M, Lazarova ML, Vaclavik J. The effect of renal denervation in patients with advanced heart failure. Eur Heart J. 2012;33:517 [Abstract Supplement].
62.
go back to reference Sobotka P, Krum H, Bohm M, Francis D, Schlaich M. The role of renal denervation in the treatment of heart failure. Curr Cardiol Rep. 2012;14:285–92.PubMedCrossRef Sobotka P, Krum H, Bohm M, Francis D, Schlaich M. The role of renal denervation in the treatment of heart failure. Curr Cardiol Rep. 2012;14:285–92.PubMedCrossRef
64.
go back to reference Gold MR, Van Veldhuisen DJ, Hauptman PJ, Borggrefe M, Kubo SH, Lieberman RA, et al. Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial. J Am Coll Cardiol. 2016;68(2):149–58.PubMedCrossRef Gold MR, Van Veldhuisen DJ, Hauptman PJ, Borggrefe M, Kubo SH, Lieberman RA, et al. Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial. J Am Coll Cardiol. 2016;68(2):149–58.PubMedCrossRef
65.
go back to reference Zannad F, De Ferrari GM, Tuinenburg AE, Wright D, Brugada J, Butter C, et al. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J. 2015;36(7):425–33.PubMedCrossRef Zannad F, De Ferrari GM, Tuinenburg AE, Wright D, Brugada J, Butter C, et al. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J. 2015;36(7):425–33.PubMedCrossRef
66.
go back to reference Lopshire JC, Zhou X, Dusa C, Ueyama T, Rosenberger J, Courtney N, et al. Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model. Circulation. 2009;120:286–94.PubMedCrossRef Lopshire JC, Zhou X, Dusa C, Ueyama T, Rosenberger J, Courtney N, et al. Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model. Circulation. 2009;120:286–94.PubMedCrossRef
67.
go back to reference Mierzewska-Schmidt M, Gawecka A. Neurogenic stunned myocardium—do we consider this diagnosis in patients with acute central nervous system injury and acute heart failure? Anaesthesiol Intensive Ther. 2015;47(2):175–80.PubMedCrossRef Mierzewska-Schmidt M, Gawecka A. Neurogenic stunned myocardium—do we consider this diagnosis in patients with acute central nervous system injury and acute heart failure? Anaesthesiol Intensive Ther. 2015;47(2):175–80.PubMedCrossRef
68.
go back to reference Bahloul M, Chaari AN, Kallel H, Khabir A, Ayadi A, Charfeddine H, et al. Neurogenic pulmonary edema due to traumatic brain injury: evidence of cardiac dysfunction. Am J Crit Care. 2006;15(5):462–70.PubMed Bahloul M, Chaari AN, Kallel H, Khabir A, Ayadi A, Charfeddine H, et al. Neurogenic pulmonary edema due to traumatic brain injury: evidence of cardiac dysfunction. Am J Crit Care. 2006;15(5):462–70.PubMed
69.
70.
go back to reference Amar D, Zhang H, Miodownik S, Kadish AH. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. J Am Coll Cardiol. 2003;42:1262–8.PubMedCrossRef Amar D, Zhang H, Miodownik S, Kadish AH. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. J Am Coll Cardiol. 2003;42:1262–8.PubMedCrossRef
71.
go back to reference Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105:2753–9.PubMedCrossRef Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105:2753–9.PubMedCrossRef
72.
go back to reference Tomita T, Takei M, Saikawa Y, Hanaoka T, Uchikawa S, Tsutsui H, et al. Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol. 2003;14:559–64.PubMedCrossRef Tomita T, Takei M, Saikawa Y, Hanaoka T, Uchikawa S, Tsutsui H, et al. Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol. 2003;14:559–64.PubMedCrossRef
73.
go back to reference Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60(1):172–8.PubMedCrossRef Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60(1):172–8.PubMedCrossRef
74.
go back to reference Linz D, Schotten U, Neuberger HR, Böhm M, Wirth K. Combined blockade of early and late activated atrial potassium currents suppresses atrial fibrillation in a pig model of obstructive apnea. Heart Rhythm. 2011;8:1933–9.PubMedCrossRef Linz D, Schotten U, Neuberger HR, Böhm M, Wirth K. Combined blockade of early and late activated atrial potassium currents suppresses atrial fibrillation in a pig model of obstructive apnea. Heart Rhythm. 2011;8:1933–9.PubMedCrossRef
75.
go back to reference Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, Neuberger HR, et al. Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension. 2013;61:225–31.PubMedCrossRef Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, Neuberger HR, et al. Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension. 2013;61:225–31.PubMedCrossRef
76.
go back to reference Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163–70.PubMedCrossRef Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163–70.PubMedCrossRef
77.
go back to reference Lomuscio A, Belletti S, Battezzati PM, Lombardi F. Efficacy of acupuncture in preventing atrial fibrillation recurrences after electrical cardioversion. J Cardiovasc Electrophysiol. 2011;22:241–7.PubMedCrossRef Lomuscio A, Belletti S, Battezzati PM, Lombardi F. Efficacy of acupuncture in preventing atrial fibrillation recurrences after electrical cardioversion. J Cardiovasc Electrophysiol. 2011;22:241–7.PubMedCrossRef
78.
go back to reference Lombardi F, Belletti S, Battezzati PM, Lomuscio A. Acupuncture for paroxysmal and persistent atrial fibrillation: an effective non-pharmacological tool? World J Cardiol. 2012;4:60–5.PubMedPubMedCentralCrossRef Lombardi F, Belletti S, Battezzati PM, Lomuscio A. Acupuncture for paroxysmal and persistent atrial fibrillation: an effective non-pharmacological tool? World J Cardiol. 2012;4:60–5.PubMedPubMedCentralCrossRef
79.
go back to reference Li S, Scherlag BJ, Yu L, Sheng X, Zhang Y, Ali R, et al. Low-level vagosympathetic stimulation: a paradox and potential new modality for the treatment of focal atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2:645–51.PubMedCrossRef Li S, Scherlag BJ, Yu L, Sheng X, Zhang Y, Ali R, et al. Low-level vagosympathetic stimulation: a paradox and potential new modality for the treatment of focal atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2:645–51.PubMedCrossRef
80.
go back to reference Yu L, Scherlag BJ, Li S, Sheng X, Lu Z, Nakagawa H, et al. Low-level vagosympathetic nerve stimulation inhibits atrial fibrillation inducibility: direct evidence by neural recordings from intrinsic cardiac ganglia. J Cardiovasc Electrophysiol. 2011;22:455–63.PubMedCrossRef Yu L, Scherlag BJ, Li S, Sheng X, Lu Z, Nakagawa H, et al. Low-level vagosympathetic nerve stimulation inhibits atrial fibrillation inducibility: direct evidence by neural recordings from intrinsic cardiac ganglia. J Cardiovasc Electrophysiol. 2011;22:455–63.PubMedCrossRef
81.
go back to reference Viskin S, Golovner M, Malov N, Fish R, Alroy I, Vila Y, et al. Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10000 episodes. Eur Heart J. 1999;20:1429–34.PubMedCrossRef Viskin S, Golovner M, Malov N, Fish R, Alroy I, Vila Y, et al. Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10000 episodes. Eur Heart J. 1999;20:1429–34.PubMedCrossRef
82.
go back to reference Olgin JE, Takahashi T, Wilson E, Vereckei A, Steinberg H, Zipes DP. Effects of thoracic spinal cord stimulation on cardiac autonomic regulation of the sinus and atrioventricular nodes. J Cardiovasc Electrophysiol. 2002;13:475–81.PubMedCrossRef Olgin JE, Takahashi T, Wilson E, Vereckei A, Steinberg H, Zipes DP. Effects of thoracic spinal cord stimulation on cardiac autonomic regulation of the sinus and atrioventricular nodes. J Cardiovasc Electrophysiol. 2002;13:475–81.PubMedCrossRef
83.
go back to reference Bernstein SA, Wong B, Vasquez C, Rosenberg SP, Rooke R, Kuznekoff LM, et al. Spinal cord stimulation protects against atrial fibrillation induced by tachypacing. Heart Rhythm. 2012;9:1426–63.PubMedPubMedCentralCrossRef Bernstein SA, Wong B, Vasquez C, Rosenberg SP, Rooke R, Kuznekoff LM, et al. Spinal cord stimulation protects against atrial fibrillation induced by tachypacing. Heart Rhythm. 2012;9:1426–63.PubMedPubMedCentralCrossRef
84.
go back to reference Lown B, Verrier R, Corbalan R. Psychologic stress and threshold for repetitive ventricular response. Science. 1973;182:834–6.PubMedCrossRef Lown B, Verrier R, Corbalan R. Psychologic stress and threshold for repetitive ventricular response. Science. 1973;182:834–6.PubMedCrossRef
85.
go back to reference Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation. 1990;82(4):1095–105.PubMedCrossRef Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation. 1990;82(4):1095–105.PubMedCrossRef
86.
go back to reference Chen LS, Zhou S, Fishbein MC, Chen PS. New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J Cardiovasc Electrophysiol. 2007;18:123–7.PubMedCrossRef Chen LS, Zhou S, Fishbein MC, Chen PS. New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J Cardiovasc Electrophysiol. 2007;18:123–7.PubMedCrossRef
87.
go back to reference Inoue H, Zipes DP. Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic. Circulation. 1987;75:877–87.PubMedCrossRef Inoue H, Zipes DP. Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic. Circulation. 1987;75:877–87.PubMedCrossRef
88.
go back to reference Cao J-M, Fishbein MC, Han JB, Lai WW, Lai AC, Hu T-J, et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation. 2000;101:1960–9.PubMedCrossRef Cao J-M, Fishbein MC, Han JB, Lai WW, Lai AC, Hu T-J, et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation. 2000;101:1960–9.PubMedCrossRef
89.
go back to reference Arora R, Ferrick KJ, Nakata T, Kaplan RC, Rozengarten M, Latif F, et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol. 2003;10:121–31.PubMedCrossRef Arora R, Ferrick KJ, Nakata T, Kaplan RC, Rozengarten M, Latif F, et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol. 2003;10:121–31.PubMedCrossRef
90.
go back to reference Schäfers M, Wichter T, Lerch H, Matheja P, Kuwert T, Schäfers K, et al. Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med. 1999;40(1):1–5.PubMed Schäfers M, Wichter T, Lerch H, Matheja P, Kuwert T, Schäfers K, et al. Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med. 1999;40(1):1–5.PubMed
91.
go back to reference Gerson MC, McGuire N, Wagoner LE. Sympathetic nervous system function as measured by I-123 metabenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy. J Card Fail. 2003;9(5):384–91.PubMedCrossRef Gerson MC, McGuire N, Wagoner LE. Sympathetic nervous system function as measured by I-123 metabenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy. J Card Fail. 2003;9(5):384–91.PubMedCrossRef
92.
go back to reference Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parízek P, Agostini D, et al. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging. 2008;1:131–40.PubMedCrossRef Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parízek P, Agostini D, et al. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging. 2008;1:131–40.PubMedCrossRef
93.
go back to reference Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55(24):2769–77.PubMedCrossRef Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55(24):2769–77.PubMedCrossRef
94.
go back to reference Kelesidis I, Travin MI. Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death. J Nucl Med. 2012;19(1):142–52. Kelesidis I, Travin MI. Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death. J Nucl Med. 2012;19(1):142–52.
95.
go back to reference Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89–95.PubMedCrossRef Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89–95.PubMedCrossRef
96.
go back to reference Janse MJ, Schwartz PJ, Wilms-Schopman F, Peters RJ, Durrer D. Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs. Circulation. 1985;72:585–95.PubMedCrossRef Janse MJ, Schwartz PJ, Wilms-Schopman F, Peters RJ, Durrer D. Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs. Circulation. 1985;72:585–95.PubMedCrossRef
97.
go back to reference Cao J-M, Chen LS, KenKnight BH, Ohara T, Lee M-H, Tsai J, et al. Nerve sprouting and sudden cardiac death. Circ Res. 2000;86:816–21.PubMedCrossRef Cao J-M, Chen LS, KenKnight BH, Ohara T, Lee M-H, Tsai J, et al. Nerve sprouting and sudden cardiac death. Circ Res. 2000;86:816–21.PubMedCrossRef
98.
go back to reference Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffmann E, et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med. 1992;327:987–92.PubMedCrossRef Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffmann E, et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med. 1992;327:987–92.PubMedCrossRef
99.
go back to reference Antz M, Cappato R, Kuck KH. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia. J Cardiovasc Pharmacol. 1995;26:627–35.PubMedCrossRef Antz M, Cappato R, Kuck KH. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia. J Cardiovasc Pharmacol. 1995;26:627–35.PubMedCrossRef
100.
go back to reference Wilde AA, Bhuiyan ZA, Crotti L, Facchini M, De Ferrari GM, Paul T. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358:2024–9.PubMedCrossRef Wilde AA, Bhuiyan ZA, Crotti L, Facchini M, De Ferrari GM, Paul T. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358:2024–9.PubMedCrossRef
102.
go back to reference Ajijola OA, Lellouche N, Bourke T, Tung R, Ahn S, Mahajan A, et al. Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol. 2012;59:91–2.PubMedPubMedCentralCrossRef Ajijola OA, Lellouche N, Bourke T, Tung R, Ahn S, Mahajan A, et al. Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol. 2012;59:91–2.PubMedPubMedCentralCrossRef
103.
go back to reference Vaseghi M, Gima J, Kanaan C, Ajijola OA, Marmureanu A, Mahajan A, et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm. 2014;11:360–6.PubMedCrossRef Vaseghi M, Gima J, Kanaan C, Ajijola OA, Marmureanu A, Mahajan A, et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm. 2014;11:360–6.PubMedCrossRef
104.
go back to reference Chinushi M, Izumi D, Iijima K, Suzuki K, Furushima H, Saitoh O, et al. Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery. Hypertension. 2013;61:450–6.PubMedCrossRef Chinushi M, Izumi D, Iijima K, Suzuki K, Furushima H, Saitoh O, et al. Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery. Hypertension. 2013;61:450–6.PubMedCrossRef
105.
go back to reference Huang B, Yu L, Scherlag BJ, Wang S, He B, Yang K, et al. Left renal nerves stimulation facilitates ischemia-induced ventricular arrhythmia by increasing nerve activity of left stellate ganglion. J Cardiovasc Electrophysiol. 2014;25:1249–56.PubMedCrossRef Huang B, Yu L, Scherlag BJ, Wang S, He B, Yang K, et al. Left renal nerves stimulation facilitates ischemia-induced ventricular arrhythmia by increasing nerve activity of left stellate ganglion. J Cardiovasc Electrophysiol. 2014;25:1249–56.PubMedCrossRef
106.
go back to reference Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension. 2013;61:457–64.PubMedCrossRef Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension. 2013;61:457–64.PubMedCrossRef
107.
go back to reference Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof of principle cohort study. Lancet. 2009;373:1275–81.PubMedCrossRef Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof of principle cohort study. Lancet. 2009;373:1275–81.PubMedCrossRef
108.
go back to reference Tsiousfis C, Papademetriou V, Tsiachris D, Dimitriadis K, Kasiakogias A, Kordalis A, et al. Drug-resistant hypertensive patients responding to multielectrode renal denervation exhibit improved heart rate dynamics and reduced arrhythmia burden. J Hum Hyperten. 2014;28:587–93.CrossRef Tsiousfis C, Papademetriou V, Tsiachris D, Dimitriadis K, Kasiakogias A, Kordalis A, et al. Drug-resistant hypertensive patients responding to multielectrode renal denervation exhibit improved heart rate dynamics and reduced arrhythmia burden. J Hum Hyperten. 2014;28:587–93.CrossRef
109.
go back to reference Kent KM, Smith ER, Redwood DR, Epstein SE. Electrical stability of acutely ischemic myocardium. influences of heart rate and vagal stimulation. Circulation. 1973;47:291–8.PubMedCrossRef Kent KM, Smith ER, Redwood DR, Epstein SE. Electrical stability of acutely ischemic myocardium. influences of heart rate and vagal stimulation. Circulation. 1973;47:291–8.PubMedCrossRef
110.
go back to reference Myers RW, Pearlman AS, Hyman RM, Goldstein RA, Kent KM, Goldstein RE, et al. Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation. 1974;49:943–7.PubMedCrossRef Myers RW, Pearlman AS, Hyman RM, Goldstein RA, Kent KM, Goldstein RE, et al. Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation. 1974;49:943–7.PubMedCrossRef
111.
go back to reference Goldstein RE, Karsh RB, Smith ER, Orlando M, Norman D, Farnham G, et al. Infuence of atropine and of vagally mediated bradycardia on the occurrence of ventricular arrhythmias following acute coronary occlusion in closed-chest dogs. Circulation. 1973;47:1180–90.PubMedCrossRef Goldstein RE, Karsh RB, Smith ER, Orlando M, Norman D, Farnham G, et al. Infuence of atropine and of vagally mediated bradycardia on the occurrence of ventricular arrhythmias following acute coronary occlusion in closed-chest dogs. Circulation. 1973;47:1180–90.PubMedCrossRef
112.
go back to reference Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991;68:1471–81.PubMedCrossRef Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991;68:1471–81.PubMedCrossRef
113.
go back to reference Vanhoutte PM, Levy MN. Prejunctional cholinergic modulation of adrenergic neurotransmission in the cardiovascular system. Am J Physiol. 1980;238:H275–81.PubMed Vanhoutte PM, Levy MN. Prejunctional cholinergic modulation of adrenergic neurotransmission in the cardiovascular system. Am J Physiol. 1980;238:H275–81.PubMed
114.
go back to reference Takahashi N, Zipes DP. Vagal modulation of adrenergic effects on canine sinus and atrioventricular nodes. Am J Physiol. 1983;244:H775–81.PubMed Takahashi N, Zipes DP. Vagal modulation of adrenergic effects on canine sinus and atrioventricular nodes. Am J Physiol. 1983;244:H775–81.PubMed
115.
go back to reference Ng GA, Brack KE, Coote JH. Effects of direct sympathetic and vagus nerve stimulation on the physiology of the whole heart-a novel model of isolated Langendorff perfused rabbit heart with intact dual autonomic innervation. Exp Physiol. 2001;86:319–29.PubMedCrossRef Ng GA, Brack KE, Coote JH. Effects of direct sympathetic and vagus nerve stimulation on the physiology of the whole heart-a novel model of isolated Langendorff perfused rabbit heart with intact dual autonomic innervation. Exp Physiol. 2001;86:319–29.PubMedCrossRef
116.
go back to reference Shinlapawittayatorn K, Chinda K, Palee S, Surinkaew S, Thunsiri K, Weerateerangkul P, et al. Low-amplitude, left vagus nerve stimulation significantly attenuates ventricular dysfunction and infarct size through prevention of mitochondrial dysfunction during acute ischemia-reperfusion injury. Heart Rhythm. 2013;10:1700–7.PubMedCrossRef Shinlapawittayatorn K, Chinda K, Palee S, Surinkaew S, Thunsiri K, Weerateerangkul P, et al. Low-amplitude, left vagus nerve stimulation significantly attenuates ventricular dysfunction and infarct size through prevention of mitochondrial dysfunction during acute ischemia-reperfusion injury. Heart Rhythm. 2013;10:1700–7.PubMedCrossRef
117.
go back to reference Issa ZF, Zhou X, Ujhelyi MR, Rosenberger J, Bhakta D, Groh WJ, et al. Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model. Circulation. 2005;111:3217–20.PubMedCrossRef Issa ZF, Zhou X, Ujhelyi MR, Rosenberger J, Bhakta D, Groh WJ, et al. Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model. Circulation. 2005;111:3217–20.PubMedCrossRef
118.
go back to reference Tse HF, Turner S, Sanders P, Okuyama Y, Fujiu K, Cheung CW, et al. Thoracic spinal cord stimulation for heart failure as a restorative treatment (SCS HEART study): first-in-man experience. Heart Rhythm. 2015;12:588–95.PubMedCrossRef Tse HF, Turner S, Sanders P, Okuyama Y, Fujiu K, Cheung CW, et al. Thoracic spinal cord stimulation for heart failure as a restorative treatment (SCS HEART study): first-in-man experience. Heart Rhythm. 2015;12:588–95.PubMedCrossRef
119.
go back to reference Evranos B, Canpolat U, Kocyigit D, Coteli C, Yorgun H, Aytemir K. Role of adjuvant renal sympathetic denervation in the treatment of ventricular arrhythmias. Am J Cardiol 2016;118(8):1207–10.PubMedCrossRef Evranos B, Canpolat U, Kocyigit D, Coteli C, Yorgun H, Aytemir K. Role of adjuvant renal sympathetic denervation in the treatment of ventricular arrhythmias. Am J Cardiol 2016;118(8):1207–10.PubMedCrossRef
Metadata
Title
Cardiac autonomic innervation
Authors
Hina K. Jamali, MD
Fahad Waqar, MD
Myron C. Gerson, MD
Publication date
01-10-2017
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 5/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0725-7

Other articles of this Issue 5/2017

Journal of Nuclear Cardiology 5/2017 Go to the issue